News
Proper legal structuring is essential when it comes to transferring Chinese biotech intellectual property and clinical assets ...
falsely claiming to be a PharmAla Biotech product and unlawfully using PharmAla logos and trademarks. PharmAla is issuing this warning in order to protect consumers and patients. PharmAla’s LaNeo MDMA ...
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research ...
With finite natural resources and a growing demand for food, the world must find ways to overcome this challenge. One ...
More information: Anne E. Robinson et al, The Biotech Explorers Pathway equips students for STEM futures, Nature Biotechnology (2025). DOI: 10.1038/s41587-025-02666-0 Journal information: Nature ...
A biotechnology firm is expanding in Bellport with assistance from the Town of Brookhaven Industrial Development Agency.
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
or wish to report suspicious products claiming association with our brand, please reach out to us directly for more information and assistance. PharmAla Biotech Holdings Inc. (CSE: MDMA ...
The biotech’s pivotal phase 2 trial is assessing the AAV9 gene therapy in 12 patients to support accelerated approval. RP-A501 is designed to fully restore cardiac function by delivering the ...
However, we lack biotech laboratory incubators that can convert our world-class science into products,” says Centre for Epidemic Response and Innovation director Professor Tulio de Oliveira.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results